The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
122947182 12294718 2 F 2010 20160628 20160422 20160706 EXP PHHY2012FR068925 NOVARTIS 59.00 YR F Y 0.00000 20160706 MD FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
122947182 12294718 1 PS AFINITOR EVEROLIMUS 1 Oral UNK 22334
122947182 12294718 2 SS AFINITOR EVEROLIMUS 1 Unknown 10 MG, QD 22334 10 MG QD
122947182 12294718 3 SS AFINITOR EVEROLIMUS 1 Unknown 5 MG, QD 22334 5 MG QD
122947182 12294718 4 SS AFINITOR EVEROLIMUS 1 7.5 MG, QD 22334 7.5 MG QD
122947182 12294718 5 C EXEMESTANE. EXEMESTANE 1 Unknown U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
122947182 12294718 1 Renal cancer metastatic
122947182 12294718 2 Renal cell carcinoma
122947182 12294718 3 Breast cancer
122947182 12294718 5 Breast cancer

Outcome of event

Event ID CASEID OUTC COD
122947182 12294718 OT
122947182 12294718 HO
122947182 12294718 DS

Reactions reported

Event ID CASEID DRUG REC ACT PT
122947182 12294718 Acute generalised exanthematous pustulosis
122947182 12294718 Aphthous ulcer
122947182 12294718 Blister
122947182 12294718 Dermatitis acneiform
122947182 12294718 Dry skin
122947182 12294718 Eczema
122947182 12294718 Epstein-Barr virus infection
122947182 12294718 Feeding disorder
122947182 12294718 Malignant neoplasm progression
122947182 12294718 Nausea
122947182 12294718 Neutropenia
122947182 12294718 Oral pain
122947182 12294718 Pruritus
122947182 12294718 Rash pustular
122947182 12294718 Skin plaque
122947182 12294718 Stomatitis
122947182 12294718 Toxic skin eruption
122947182 12294718 Weight decreased
122947182 12294718 Wound

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
122947182 12294718 1 2010 0
122947182 12294718 2 20150214 20150304 0
122947182 12294718 3 20150318 20150513 0
122947182 12294718 4 20150514 20151118 0